Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.100
-0.070 (-3.23%)
Dec 20, 2024, 4:00 PM EST - Market closed
Entera Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 0.1 | - | 0.13 | 0.57 | 0.37 | 0.24 | Upgrade
|
| Revenue Growth (YoY) | 607.14% | - | -76.53% | 56.44% | 54.66% | -52.80% | Upgrade
|
| Cost of Revenue | 0.09 | - | 0.1 | 0.37 | 0.3 | 0.21 | Upgrade
|
| Gross Profit | 0.01 | - | 0.03 | 0.2 | 0.07 | 0.03 | Upgrade
|
| Selling, General & Admin | 4.93 | 4.43 | 7.71 | 5.69 | 4.85 | 4.28 | Upgrade
|
| Research & Development | 4.3 | 4.51 | 5.85 | 6.77 | 6.38 | 7.2 | Upgrade
|
| Other Operating Expenses | -0.01 | -0.05 | -0.05 | -0.05 | - | - | Upgrade
|
| Operating Expenses | 9.22 | 8.89 | 13.51 | 12.42 | 11.23 | 11.48 | Upgrade
|
| Operating Income | -9.21 | -8.89 | -13.47 | -12.22 | -11.17 | -11.45 | Upgrade
|
| Interest Expense | - | - | - | - | -0.03 | -0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0.03 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.03 | 0.08 | - | - | 0.74 | Upgrade
|
| EBT Excluding Unusual Items | -9.18 | -8.86 | -13.39 | -12.25 | -11.2 | -10.8 | Upgrade
|
| Other Unusual Items | - | - | 0.46 | - | - | - | Upgrade
|
| Pretax Income | -9.18 | -8.86 | -12.93 | -12.25 | -11.2 | -10.8 | Upgrade
|
| Income Tax Expense | - | 0.03 | 0.14 | -0.06 | 0.02 | - | Upgrade
|
| Net Income | -9.18 | -8.89 | -13.07 | -12.19 | -11.22 | -10.8 | Upgrade
|
| Net Income to Common | -9.18 | -8.89 | -13.07 | -12.19 | -11.22 | -10.8 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 29 | 29 | 26 | 18 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 29 | 29 | 26 | 18 | 12 | Upgrade
|
| Shares Change (YoY) | 22.42% | 0.69% | 10.23% | 41.90% | 51.62% | 52.15% | Upgrade
|
| EPS (Basic) | -0.26 | -0.31 | -0.45 | -0.47 | -0.61 | -0.89 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.31 | -0.45 | -0.47 | -0.61 | -0.89 | Upgrade
|
| Free Cash Flow | -7.97 | -7.33 | -12.55 | -9.08 | -10.61 | -8.96 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.25 | -0.44 | -0.35 | -0.58 | -0.74 | Upgrade
|
| Gross Margin | 9.09% | - | 24.63% | 34.68% | 17.81% | 11.02% | Upgrade
|
| Operating Margin | -9304.04% | - | -10055.22% | -2139.58% | -3059.73% | -4853.39% | Upgrade
|
| Profit Margin | -9270.71% | - | -9754.48% | -2134.33% | -3072.88% | -4574.15% | Upgrade
|
| Free Cash Flow Margin | -8053.54% | - | -9362.69% | -1590.19% | -2906.85% | -3796.19% | Upgrade
|
| EBITDA | -9.16 | -8.84 | -13.41 | -12.16 | -11.11 | -11.35 | Upgrade
|
| D&A For EBITDA | 0.05 | 0.06 | 0.06 | 0.05 | 0.06 | 0.11 | Upgrade
|
| EBIT | -9.21 | -8.89 | -13.47 | -12.22 | -11.17 | -11.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.